Primary effect of chemotherapy on the transcription profile of AIDS-related Kaposi's sarcoma

BMC Cancer

Volumn 2, Issue , 2002, Pages

  van der Kuyl, Antoinette C ^a   van den Burg, Remco ^a   Zorgdrager, Fokla ^a   Dekker, John T ^b   Maas, Jolanda ^b   van Noesel, Carel J M ^a   Goudsmit, Jaap ^c   Cornelissen, Marion ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b PrimaGen BV   (Netherlands)

^c CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BLEOMYCIN; CD4 ANTIGEN; DOXORUBICIN; MESSENGER RNA; MITOCHONDRIAL RNA; POLYADENYLIC ACID BINDING PROTEIN; RIBONUCLEOPROTEIN; RIBOSOME RNA; VINCRISTINE; POLYADENYLIC ACID; RNA; RNA, MITOCHONDRIAL;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMATIN STRUCTURE; COMPUTER PROGRAM; DNA DAMAGE; DNA REPLICATION; DNA SYNTHESIS INHIBITION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETIC DATABASE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IN VIVO STUDY; KAPOSI SARCOMA; LYMPHOCYTIC INFILTRATION; MALE; MITOSIS INHIBITION; RNA ISOLATION; RNA TRANSCRIPTION; SERIAL ANALYSIS OF GENE EXPRESSION; SEROLOGY; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMPARATIVE STUDY; GENE; GENE EXPRESSION PROFILING; GENETICS; METHODOLOGY; SKIN TUMOR; TIME; TUMOR GENE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; GENES; GENES, NEOPLASM; HUMANS; POLY A; RNA; RNA, MESSENGER; RNA, NEOPLASM; SARCOMA, KAPOSI; SKIN NEOPLASMS; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 3042719090     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-2-21     Document Type: Article

References (56)

1. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, et al: A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000, 24:236-244
2. Jordan MA, Thrower D, Wilson L: Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 1991, 51:2212-2222
3. Barlogie B, Drewinko B, Johnston DA, Freireich EJ: The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line. Cancer Res 1976, 36:1975-1979
4. Mimnaugh EG, Trush MA, Bhatnagar M, Gram TE: Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin. Biochem Pharmacol 1985, 34:847-856
5. Cullinane C, Cutts SM, Panousis C, Phillips DR: Interstrand crosslinking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells. Nucleic Acids Res 2000, 28:1019-1025
6. Eliot H, Gianni L, Myers C: Oxidative destruction of DNA by the adriamycin-iron complex. Biochemistry 1984, 23:928-936
7. Muindi J, Sinha BK, Gianni L, Myers C: Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms. Mol Pharmacol 1985, 27:356-365
8. Muindi JR, Sinha BK, Gianni L, Myers CE: Hydroxyl radical production and DNA damage induced by anthracycline-iron complex. FEBS Lett 1984, 172:226-230
9. Myers C, Gianni L, Zweier J, Muindi J, Sinha BK, Eliot H: Role of iron in adriamycin biochemistry. Fed Proc 1986, 45:2792-2797
10. Maniglia CA, Wilson RG: Two types of adriamycin inhibition of a homologous RNA synthesizing system from L1210 cells. Chem Biol Interact 1981, 33:319-327
11. Zhu K, Henning D, Iwakuma T, Valdez BC, Busch H: Adriamycin inhibits human RH II/Gu RNA helicase activity by binding to its substrate. Biochem Biophys Res Commun 1999, 266:361-365
12. Gewirtz DA: A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999, 57:727-741
13. Barlogie B, Drewinko B, Schumann J, Freireich EJ: Pulse cytophotometric analysis of cell cycle perturbation with bleomycin in vitro. Cancer Res 1976, 36:1182-1187
14. Noda A: Gene expression in ataxia telangiectasia cells as perturbed by bleomycin treatment. Somat Cell Mol Genet 1992, 18:113-122
15. Kuo MT, Auger LT, Saunders GF, Haidle CW: Effect of bleomycin on the synthesis and function of RNA. Cancer Res 1977, 37:1345-1348
16. Vernole P, Tedeschi B, Caporossi D, Maccarrone M, Melino G, Annicchiarico-Petruzzelli M: Induction of apoptosis by bleomycin in resting and cycling human lymphocytes. Mutagenesis 1998, 13:209-215
17. Iqbal ZM, Kohn KW, Ewig RA, Fornace AJ Jr: Single-strand scission and repair of DNA in mammalian cells by bleomycin. Cancer Res 1976, 36:3834-3838
18. D'Andrea AD, Haseltine WA: Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin. Proc Natl Acad Sci U S A 1978, 75:3608-3612
19. Kuo MT: Preferential damage of active chromatin by bleomycin. Cancer Res 1981, 41:2439-2443
20. Hecht SM: Bleomycin: new perspectives on the mechanism of action. J Nat Prod 2000, 63:158-168
21. Yamamoto T, Eckes B, Krieg T: Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Arch Dermatol Res 2000, 292:556-561
22. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M: Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 1998, 275:L365-L371
23. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 1995, 270:484-487
24. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000, 60:6281-6287
25. Waghray A, Schober M, Feroze F, Yao F, Virgin J, Chen YQ: Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. Cancer Res 2001, 61:4283-4286
26. Ryu B, Jones J, Hollingsworth MA, Hruban RH, Kern SE: Invasionspecific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 2001, 61:1833-1838
27. Moore PS, Chang Y: Antiviral activity of tumor-suppressor pathways: Clues from molecular piracy by KSHV. Trends in Genetics 1998, 14:144-150
28. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Sturzl M: Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. Journal of Virology 1997, 71:7963-7968
29. Cerimele F, Curreli F, Ely S, Friedman-Kien AE, Cesarman E, Flore O: Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. J Virol 2001, 75:2435-2443
30. Moses AV, Fish KN, Ruhl R, Smith PP, Strussenberg JG, Zhu L, Chandran B, Nelson JA: Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol 1999, 73:6892-6902
31. Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, Knowles DM, Asch AS: Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996, 183:2385-2390
32. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 1995, 332:1186-1191
33. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, D'Agay M-F, Clauvel J-P, Raphael M, Degos L, et al: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86:1276-1280
34. Khanna N, Reddy VG, Tuteja N, Singh N: Differential gene expression in apoptosis: identification of ribosomal protein S29 as an apoptotic inducer. Biochem Biophys Res Commun 2000, 277:476-486
35. Collins I, Weber A, Levens D: Transcriptional consequences of topoisomerase inhibition. Mol Cell Biol 2001, 21:8437-8451
36. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA: Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A 2000, 97:1778-1783
37. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, Chin KV: Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 2000, 60:4161-4166
38. Dan S, Yamori T: Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells. Biochem Biophys Res Commun 2001, 280:861-867
39. Demaria S, Volm MD, Shapiro RL, Yee HT, Oratz R, Formenti SC, Muggia F, Symmans WF: Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy. Clin Cancer Res 2001, 7:3025-3030
40. Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, Giltnane JM, Averett LM, Zhao H, Davis RE, Sathyamoorthy M, et al: Genomicscale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol 2001, 2:RESEARCH0041
41. Guhaniyogi J, Brewer G: Regulation of mRNA stability in mammalian cells. Gene 2001, 265:11-23
42. Hendrickson S, Johnson LF: Evidence for highly stable nuclear poly(A) in cultured mammalian cells. Biochim Biophys Acta 1978, 517:287-295
43. . Spector DL: Macromolecular domains within the cell nucleus. Annu Rev Cell Biol 1993, 9:265-315
44. Huang S, Deerinck TJ, Ellisman MH, Spector DL: The perinucleolar compartment and transcription. J Cell Biol 1998, 143:35-47
45. Brawerman G, Diez J: Metabolism of the polyadenylate sequence of nuclear RNA and messenger RNA in mammalian cells. Cell 1975, 5:271-280
46. Mintz PJ, Patterson SD, Neuwald AF, Spahr CS, Spector DL: Purification and biochemical characterization of interchromatin granule clusters. EMBO J 1999, 18:4308-4320
47. Tenenbaum SA, Carson CC, Lager PJ, Keene JD: Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci U S A 2000, 97:14085-14090
48. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, Nevins JR: Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 2001, 21:4684-4699
49. Ling YH, el Naggar AK, Priebe W, Perez-Soler R: Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol 1996, 49:832-841
50. Aytac U, Claret FX, Ho L, Sato K, Ohnuma K, Mills GB, Cabanillas F, Morimoto C, Dang NH: Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint. Cancer Res 2001, 61:7204-7210
51. Colgan DF, Murthy KG, Prives C, Manley JL: Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature 1996, 384:282-285
52. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science 1997, 276:1268-1272
53. van Kampen AH, van Schaik BD, Pauws E, Michiels EM, Ruijter JM, Caron HN, Versteeg R, Heisterkamp SH, Leunissen JA, Baas F, et al: USAGE: a web-based approach towards the analysis of SAGE data. Bioinformatics 2000, 16:899-905
54. Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, van Sluis P, Hermus MC, van Asperen R, Boon K, Voute PA, et al: The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science 2001, 291:1289-1292
55. Kal AJ, van Zonneveld AJ, Benes V, van den Berg M, Koerkamp MG, Albermann K, Strack N, Ruijter JM, Richter A, Dujon B, et al: Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell 1999, 10:1859-1872
56. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci S U A 1998, 95:14863-14868